MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
46.75
+0.47
+1.02%
After Hours: 46.75 0 0.00% 16:10 02/10 EST
OPEN
46.24
PREV CLOSE
46.28
HIGH
46.88
LOW
46.04
VOLUME
309.53K
TURNOVER
--
52 WEEK HIGH
50.79
52 WEEK LOW
23.23
MARKET CAP
1.48B
P/E (TTM)
29.16
1D
5D
1M
3M
1Y
5Y
1D
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
TipRanks · 14h ago
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP), Wave Life Sciences (WVE) and Collegium Pharmaceutical (COLL)
TipRanks · 16h ago
Weekly Report: what happened at COLL last week (0202-0206)?
Weekly Report · 1d ago
Collegium Pharmaceutical management to meet with Truist
TipRanks · 5d ago
What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders
Simply Wall St · 02/02 21:18
Weekly Report: what happened at COLL last week (0126-0130)?
Weekly Report · 02/02 09:51
Weekly Report: what happened at COLL last week (0119-0123)?
Weekly Report · 01/26 09:51
Collegium Pharmaceutical: Buying The Projected Growth For 2026
Seeking Alpha · 01/22 03:45
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.